Our results suggest that NR6A1, CXCL5, C3, and TGFB1 are critical DEIRGs in sorafenib-resistant cells, which are markedly associated with the survival time of HCC patients and infiltration levels of immune cells. The gene discussed is NR6A1; the disease is hepatocellular carcinoma.